March 13 (Reuters) - Australian Pharmaceutical Industries Ltd API.AX :
* CLEAR THAT API'S NBIO TO PURSUE A MERGER OF API AND SIGMA IS UNABLE TO BE TAKEN FORWARD
* IS REVIEWING ITS SHAREHOLDING IN SIGMA WHICH IT ACQUIRED IN LATTER PART OF 2018
* API HAS CLOSED ITS DATA ROOM AND IS REVIEWING ITS SHAREHOLDING IN SIGMA WHICH IT ACQUIRED IN LATTER PART OF 2018